Tag Archives: Neuprogen

Novartis Wins Landmark Biosimilar Approval

Novartis Navigates The FDA-ACA Maze – Gets Approval For Generic Neuprogen. Amgen will soon find itself in a price war with Sandoz – a Novartis company – as it tries to maintain its share of the market for Neuprogen (filgraslim). … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , | Leave a comment